Stock UniverseDerived research view · source repositories remain read-only

Harrow, Inc. (HROW)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
31.99
Global Rank
1663
Market Cap
2.01B
Latest Close
33.19
RS Composite
-27.60% · G#2945

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-17.58%
3M
-8.69%
6M
-25.45%
1Y
12.47%
3Y
75.98%
5Y
260.76%
10Y
751.03%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 637.01K · 30-day average: 901.93K · Max drawdown over stored range: -71.15%

Research Snapshot

Relative Strength vs SPX

RS Composite-27.60%
20D RS-15.64%
60D RS-19.12%
120D RS-42.04%
Global RS Rank2945 · 12.22% percentile
Watch+Speculative RS Rank1807 · 13.83% percentile
Group ScopeWatch+Speculative
Primary RS Rank350 · 23.58% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank204 / 701
Primary Percentile71.04
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-11268.68M199.11M19.67M-14.96M-0.3953.74M1.42M52.32M38M74.11%7.32%-5.57%20.00%19.47%94.64M300.00M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.39-84.4x$7.064.7x$1.3724.1x$1.4123.5x

Shares Diluted: 38M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue48.87172.47688.595130.193199.614272.303
Revenue Growth (YoY)-4.484%48.301%22.24%46.953%53.322%36.415%
Gross Profit34.40854.26263.21290.553150.369
Operating Income0.7483.3631.9190.8119.075
Free Cash Flow-1.9623.296-0.8922.38-23.79742.977
Free Cash Flow Per Share-0.0760.123-0.0320.073-0.6681.1691093863050304
EPS (Diluted) GAAP-0.129637-0.690611-0.512946-0.748418-0.49034
EPS Growth10300%10300%10300%10300%10300%
EPS Non-GAAP
Gross Margin70.406%74.869%71.349%69.553%75.33%75.0521%
Operating Margin1.531%4.64%2.166%0.623%4.546%11.2063%
Profit Margin-6.869%-25.497%-15.899%-18.75%-8.757%-1.8872%
Free Cash Flow Margin-4.015%4.548%-1.007%1.828%-11.922%15.7828%
Shares Outstanding (Diluted)25.895426.757527.46132.616835.650736.7605
Shares Change (YoY)-2.157%3.329%2.629%18.775%9.302%3.113%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-1144.20M61.18%-22.08M-49.95%-27.60M-62.44%-0.7437.23M94.64M300.00Mprocessed
2025 Q42026-03-0289.09M79.27%15.59M17.50%6.63M7.44%0.1837.28M72.93M250.00Mprocessed
2025 Q32025-11-1071.64M75.28%14.75M20.59%1.02M1.42%0.0338.88M74.29M347.24Mprocessed
2025 Q22025-08-1163.74M74.54%11.41M17.90%5.00M7.84%0.1338.85M52.96M250.62Mprocessed
2025 Q12025-05-0847.83M67.54%-11.23M-23.48%-17.78M-37.17%-0.5035.83M66.73M256.91Mprocessed
2024 Q42025-03-2766.83M78.85%12.90M19.30%6.78M10.14%0.1935.81M55.93M262.74Mprocessed
2024 Q32024-11-1449.26M75.60%1.32M2.68%-4.22M-8.57%-0.1235.70M81.28M230.65Mprocessed
2024 Q22024-08-0748.94M74.38%1.53M3.13%-6.47M-13.23%-0.1835.62M79.65M236.26Mprocessed
2024 Q12024-05-1334.59M69.49%-6.93M-20.03%-13.56M-39.22%-0.3835.47M75.97M243.44Mprocessed
2023 Q42024-03-1936.35M68.91%-4.88M-13.41%-9.15M-25.16%-0.2635.40M82.77M246.72Mprocessed
2023 Q32023-11-1334.27M70.62%1.74M5.09%-4.39M-12.81%-0.1334.26M73.88M251.98Mprocessed
2023 Q22023-08-0933.47M70.12%2.35M7.03%-4.23M-12.64%-0.1430.46M29.67M240.25Mprocessed
2023 Q12023-05-1126.10M68.31%1.21M4.64%-6.64M-25.45%n/a30.29M26.88M243.89Mprocessed
2022 Q42023-03-2320.33M69.67%-1.78M-8.75%1.05M5.19%n/an/a101.86M151.77Mprocessed
2022 Q32022-11-1422.82M70.55%-94.00K-0.41%-6.46M-28.32%n/an/a49.12M98.18Mprocessed
2022 Q22022-08-0923.32M71.98%1.69M7.25%-6.24M-26.75%n/an/a51.63M99.80Mprocessed
2022 Q12022-05-0522.12M73.04%2.10M9.50%-2.44M-11.02%-0.0927.23M50.59M101.42Mprocessed
2021 Q42022-03-1020.19M74.84%-1.75M-8.69%-7.42M-36.74%n/an/a42.17M103.03Mprocessed
2021 Q32021-11-0918.71M73.56%-3.72M-19.87%-8.33M-44.51%-0.3127.11M67.84M106.19Mprocessed
2021 Q22021-08-1018.13M75.64%4.17M22.99%-2.48M-13.66%n/an/a85.06M106.73Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.